Naloxone Hydrochloride Injection, Solution
Product Images NDC 72603-590

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 72603-590). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (B47cd407 70d8 4033 930d 9df4539be95c 01)

This text mentions the chemical compound "Naloxone Hydrochloride," which is a medication used to counteract opioid overdose by reversing the effects of opioids in the body. Naloxone works by binding to the same receptors as opioids, blocking their effects and restoring normal respiration.*

FDA Label Image

Viallabel (B47cd407 70d8 4033 930d 9df4539be95c 02)

This is a product description for an injectable solution containing Naloxone HCI with a concentration of 0.4 mg/mL. It is intended for intravenous, intramuscular, or subcutaneous use, packaged in a 1 mL single-dose vial. The vial is to be protected from light and has an expiration date given as 12006828. The product is manufactured for Northstar Rx LLC by Mankind Pharma Limited.*

FDA Label Image

10scarton (B47cd407 70d8 4033 930d 9df4539be95c 03)

This is a description of a product called Naloxone Hydrochloride Injection, USP with a concentration of 0.4 mg/mL intended for intravenous, intramuscular, or subcutaneous use. It comes in a package containing 10 single-dose vials. The text provides instructions for proper storage, handling, and administration of the medication. Additionally, it mentions the manufacturer as well as some technical details on the drug composition.*

FDA Label Image

25s Carton (B47cd407 70d8 4033 930d 9df4539be95c 04)

This description provides details about Naloxone Hydrochloride Injection in single-dose vials containing 0.4 mg/mL for intravenous, intramuscular, or subcutaneous use. The text includes instructions on usage, storage conditions, manufacturer information, and dosage guidelines. It also emphasizes the importance of using aseptic technique and following proper disposal guidelines for unused portions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.